Follow
John H. Van Drie
John H. Van Drie
Van Drie Research LLC
Verified email at vandrieresearch.com - Homepage
Title
Cited by
Cited by
Year
Design, Activity, and 2.8 Å Crystal Structure of a C2 Symmetric Inhibitor Complexed to HIV-1 Protease
J Erickson, DJ Neidhart, J VanDrie, DJ Kempf, XC Wang, DW Norbeck, ...
Science 249 (4968), 527-533, 1990
7881990
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
LM Lasko, CG Jakob, RP Edalji, W Qiu, D Montgomery, EL Digiammarino, ...
Nature 550 (7674), 128-132, 2017
5612017
Structure− activity landscape index: identifying and quantifying activity cliffs
R Guha, JH Van Drie
Journal of chemical information and modeling 48 (3), 646-658, 2008
3412008
ALADDIN: An integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional …
JH Van Drie, D Weininger, YC Martin
Journal of Computer-Aided Molecular Design 3, 225-251, 1989
2731989
Computer-aided drug design: the next 20 years
JH Van Drie
Journal of computer-aided molecular design 21 (10), 591-601, 2007
2142007
Navigating structure–activity landscapes
J Bajorath, L Peltason, M Wawer, R Guha, MS Lajiness, JH Van Drie
Drug discovery today 14 (13-14), 698-705, 2009
1842009
Pharmacophore discovery-lessons learned
JH Van Drie
Current pharmaceutical design 9 (20), 1649-1664, 2003
1632003
Approaches to virtual library design
JH Van Drie, MS Lajiness
Drug Discovery Today 3 (6), 274-283, 1998
1261998
Inhibitors of hepatitis C virus NS3· 4A protease 2. Warhead SAR and optimization
RB Perni, J Pitlik, SD Britt, JJ Court, LF Courtney, DD Deininger, ...
Bioorganic & Medicinal Chemistry Letters 14 (6), 1441-1446, 2004
1022004
Assessing how well a modeling protocol captures a structure− activity landscape
R Guha, JH Van Drie
Journal of chemical information and modeling 48 (8), 1716-1728, 2008
902008
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
J Pitlik, KM Cottrell, LJ Farmer, RB Perni, LF Courtney, JH Van Drie, ...
US Patent 7,273,885, 2007
872007
Inhibitors of hepatitis C virus NS3· 4A protease. Part 3: P2 proline variants
RB Perni, LJ Farmer, KM Cottrell, JJ Court, LF Courtney, DD Deininger, ...
Bioorganic & Medicinal Chemistry Letters 14 (8), 1939-1942, 2004
722004
Bridged bicyclic serine protease inhibitors
LJ Farmer, J Pitlik, RB Perni, LF Courtney, J Van Drie
US Patent 6,909,000, 2005
712005
Strategies for the determination of pharmacophoric 3D database queries
JHV Drie
Journal of computer-aided molecular design 11, 39-52, 1997
711997
Enhancement of binary QSAR analysis by a GA-based variable selection method
H Gao, MS Lajiness, J Van Drie
Journal of Molecular Graphics and Modelling 20 (4), 259-268, 2002
672002
Monty Kier and the origin of the pharmacophore concept
JH Van Drie
Internet Electronic Journal of Molecular Design 6 (9), 271-279, 2007
662007
Discovery of spiro oxazolidinediones as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases
MR Michaelides, A Kluge, M Patane, JH Van Drie, C Wang, TM Hansen, ...
ACS medicinal chemistry letters 9 (1), 28-33, 2018
592018
Cryo-EM as a powerful tool for drug discovery
JH Van Drie, L Tong
Bioorganic & medicinal chemistry letters 30 (22), 127524, 2020
552020
Inhibitors of hepatitis C virus NS3· 4A protease 1. Non-Charged tetrapeptide variants
RB Perni, SD Britt, JC Court, LF Courtney, DD Deininger, LJ Farmer, ...
Bioorganic & Medicinal Chemistry Letters 13 (22), 4059-4063, 2003
552003
Protein folding, protein homeostasis, and cancer
JH Van Drie
Chinese journal of cancer 30 (2), 124, 2011
542011
The system can't perform the operation now. Try again later.
Articles 1–20